Cargando…
Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report
Chemotherapy-related encephalopathy is a rare but severe side effect of cancer therapy. Few reports exist on the course of encephalopathy due to 5-fluorouracil (5FU)/carboplatin treatment. Here, we report on a patient in his 70s, who received first-line palliative treatment with carboplatin followed...
Autores principales: | Zupancic, Mark, Farrajota Neves da Silva, Pedro, Kas Elyas, Karam, Friesland, Signe, Ellingsen Cederö, Thomasine, Gerling, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359680/ https://www.ncbi.nlm.nih.gov/pubmed/37485017 http://dx.doi.org/10.1159/000531472 |
Ejemplares similares
-
Alpha coma in COVID encephalopathy
por: Nuwer, Marc R.
Publicado: (2021) -
Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma
por: Dechaphunkul, Tanadech, et al.
Publicado: (2011) -
Cadasil coma: Unusual cause for acute encephalopathy
por: Eswaradass, Venkatesan Prasanna, et al.
Publicado: (2015) -
Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)
por: Tsakonas, Georgios, et al.
Publicado: (2020) -
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort
por: Zupancic, Mark, et al.
Publicado: (2023)